Unknown

Dataset Information

0

Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.


ABSTRACT: For many liver diseases, including viral and autoimmune hepatitis, immune cells play an important role in the development and progression of liver injury. Concanavalin A (Con A) administration to rodents has been used as a model of immune-mediated liver injury resembling human autoimmune hepatitis. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) has been demonstrated to alter the development of immune-mediated diseases. Mice pretreated with TCDD developed exacerbated liver injury in response to administration of a mild dose (6 mg/kg) of Con A. In the present study, we tested the hypothesis that TCDD pretreatment exacerbates Con A-induced liver injury by enhancing the activation and recruitment of accessory cell types including neutrophils, macrophages, and natural killer (NK) cells. Mice were treated with 0, 0.3, 3, or 30 ?g/kg TCDD and 4 days later with Con A or saline. TCDD pretreatment with doses of 3 and 30 ?g/kg significantly increased liver injury from Con A administration. The plasma concentrations of neutrophil chemokines were significantly increased in TCDD-pretreated mice after Con A administration. NKT cell-deficient (CD1d KO) mice were used to examine whether NKT cells were required for TCDD/Con A-induced liver injury. CD1d KO mice were completely protected from liver injury induced by treatment with Con A alone, whereas the injury from TCDD/Con A treatment was reduced but not eliminated. However, T-cell deficient (RAG1 KO) mice were protected from liver injury induced by Con A irrespective of pretreatment with TCDD. TCDD/Con A treatment increased the percentage of NK cells expressing the activation marker CD69. Depletion of NK cells prior to treatment resulted in significant reductions in plasma interferon-? and liver injury from TCDD/Con A treatment. In summary, exposure to TCDD exacerbated the immune-mediated liver injury induced by Con A, and our findings suggest that NK cells play a critical role in this response.

SUBMITTER: Fullerton AM 

PROVIDER: S-EPMC3829569 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.

Fullerton Aaron M AM   Roth Robert A RA   Ganey Patricia E PE  

Toxicological sciences : an official journal of the Society of Toxicology 20130822 1


For many liver diseases, including viral and autoimmune hepatitis, immune cells play an important role in the development and progression of liver injury. Concanavalin A (Con A) administration to rodents has been used as a model of immune-mediated liver injury resembling human autoimmune hepatitis. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) has been demonstrated to alter the development of immune-mediated diseases. Mice pretreated with TCDD developed exacerbated liver injury in response to admin  ...[more]

Similar Datasets

| S-EPMC3535831 | biostudies-literature
| S-EPMC6969644 | biostudies-literature
| S-EPMC5966527 | biostudies-literature
| S-EPMC8763799 | biostudies-literature
| S-EPMC7312313 | biostudies-literature
| S-EPMC5682941 | biostudies-literature
| S-EPMC6330470 | biostudies-literature
| S-EPMC9944334 | biostudies-literature
| S-EPMC8447939 | biostudies-literature
| S-EPMC6943453 | biostudies-literature